Aug. 26 Company Quick Takes: J&J ordered to pay $572M in opioid trial; plus Taltz, CVRx and Crozet

J&J to appeal ruling in Oklahoma suit
Oklahoma Judge Thad Balkman ruled that J&J's "misleading marketing and promotion of opioids" compromised the health and safety of thousands

Read the full 261 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE